← Back to Patent Explorer
WO1990012878A1 Expired / Lapsed WO ⏱️ 0.0 years remaining

Improvements in or relating to enhancers

Assignee: Medical Research Council
•
Filing: 1990-04-20
•
Granted: —
•
Expires: 2010-04-20
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A novel enhancer, known as the K3'-enhancer, has been identified in the mouse immunoglobulin K locus, downstream of CK. The K3'-enhancer is B cell specific, is some sevenfold stronger than the K-intron enhancer and the region of the enhancer shows striking sequence homologies to the lymphotopic papovavirus, IgH and K-intron enhancers. The novel enhancer allows high level expression both in transfected cell lines and in transgenic mice, and may thus be used to enhance expression of genes in host cells, in vivo and in vitro. The novel enhancer is also found to increase somatic mutation of antibody genes in transgenic mice. The novel enhancer can also be used in gene therapy. Functionally equivalent enhancers are to be expected to occur downstream of CK of the immunoglobulin K locus of other species.

Inventors

  • 👤 Michael Samuel Neuberger
  • 👤 Kerstin Barbara Meyer

Bibliographic Details

Application Number —
Jurisdiction WO
Data Source google_patents
Last Synchronized 2026-10-23 05:23
CPC Classifications
C; C12; C12N; C12N15/00; C12N15/09; C12N15/63; C12N15/79; C12N15/85; A; A61; A61K; A61K48/00; C12N2830/00; C12N2830/30; C12N2830/60

Claims Analysis

Total Claims: 0
No claims parsed yet. Click Sync Now above to re-index claims from Google Patents.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Maintenance schedule is calculated for granted US utility patents.

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag